Surgical experiences of intraductal papillary mucinous neoplasms of the pancreas at a single Japanese Institute: Characteristics of malignant histology

Hepato-Gastroenterology

Volumn 55, Issue 88, 2008, Pages 2238-2241

  Nanashima, Atsushi ^a   Sumida, Yorihisa ^a   Abo, Takafumi ^a   Oikawa, Masahiro ^a   Takeshita, Hiroaki ^a   Hidaka, Shigekazu ^a   Sawai, Terumitsu ^a   Yasutake, Toru ^a   Kinoshita, Naoe ^a   Hayashi, Tomayoshi ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Intraductal papillary mucinous neoplasms; Invasiveness; Pancreas

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COLON CANCER; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; ESOPHAGUS CANCER; FEMALE; GALLBLADDER CANCER; HEART ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; JAPAN; KIDNEY CARCINOMA; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREAS SURGERY; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TREATMENT INDICATION; TREATMENT OUTCOME; TUBERCULOSIS; UTERUS CANCER;

AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROGNOSIS;

EID: 60849109533     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K: Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol. 2006; 40:856-862.
2. Yamaguchi K, Nakamura M, Shirahane K, Kawamoto M, Konomi H, Ohta M, Tanaka M: Pancreatic juice cytology in IPMN of the pancreas. Pancreatology. 2005; 5:416-421.
3. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S; International Association of Pancreatology: International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; 6:17-32.
4. Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, Lauwers GY, Shimizu M: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol. 2006; 30:1561-1569.
5. Furukawa T, Kloppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, Hruban RH, Kato Y, Klimstra DS, Longnecker DS, Lóttges J, Offerhaus GJ, Shimizu M, Sunamura M, Suriawinata A, Takaori K, Yonezawa S: Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005; 447:794-799.
6. Japan Pancreas Society: Explanation of the histological classification. In: Kawarada Y(eds). Classification of pancreatic carcinoma. 2nd English ed. Tokyo: Kanehara & Co., Ltd; 2003. pp 22-33.
7. Inagaki M, Obara M, Kino S, Goto J, Suzuki S, Ishizaki A, Tanno S, Kohgo Y, Tokusashi Y, Miyokawa N, Kasai S: Pylorus-preserving total pancreatectomy for an intraductal papillary-mucinous neoplasm of the pancreas. J Hepato-biliary Pancreat Surg. 2007; 4:264-269.
8. Tanaka M, Kobayashi K, Mizumoto K, Yamaguchi K: Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2005; 40:669-675.
9. Tanaka M: Important clues to the diagnosis of pancreatic cancer. Rocz Akad Med Bialymst. 2005; 50:69-72.
10. Siveke JT, Einwächter H, Sipos B, Lubeseder-Martellato C, Klöppel G, Schmid RM: Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell. 2007; 12:266-279.
11. Kang CM, Kim JY, Choi GH, Kim KS, Choi JS, Lee WJ, Kim BR: The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer. J Surg Res. 2007 1; 140:31-35.
12. Pelaez-Luna M, Chari ST, Smyrk TC, Takahashi N, Clain JE, Levy MJ, Pearson RK, Petersen BT, Topazian MD, Vege SS, Kendrick M, Farnell MB: Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007; 102:1759-1764.
13. Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, Kim SC, Han DJ, Choi DW, Choi SH, Heo JS, Cho BH, Yu HC, Yoon DS, Lee WJ, Lee HE, Kang GH, Lee JM: Treatment Guidelines for Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: When Can We Operate or Observe? Ann Surg Oncol. 2008; 15:199-205.
14. Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, Howard TJ, Zyromski NJ, Nakeeb A, DeWitt JM, Akisik FM, Sherman S, Pitt HA, Lillemoe KD: Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007; 246:644-651.
15. Glasgow RE, Jackaon HH, Neumayer L, Schifftner TL, Khuri SF, Henderson WG, Mulvihill SJ: Pancreatic resection in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study. J Am Coll Surg. 2007; 204:1252-1260.
16. Falconi M, Salvia R, Bassi C, Zamboni G, Talamini G, Pederzoli P: Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg. 2001; 88:376-381.
17. Sugiura H, Kondo S, Islam HK, Ito K, Ono K, Morikawa T, Okushiba S, Katoh H: Clinicopathologic features and outcomes of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology. 2002; 49:263-267.
18. Inagaki M, Obara M, Kino S, Goto J, Suzuki S, Ishizaki A, Tanno S, Kohgo Y, Tokusashi Y, Miyokawa N, Kasai S: Pylorus-preserving total pancreatectomy for an intraductal papillary-mucinous neoplasm of the pancreas. J Hepatobiliary Pancreat Surg. 2007; 14:264-269.
19. Yamaguchi K, Konomi H, Kobayashi K, Ogura Y, Sonoda Y, Kawamoto M, Nakano K, Tanaka M: Total pancreatectomy for intraductal papillary-mucinous tumor of the pancreas: reappraisal of total pancreatectomy. Hepatogastroenterology. 2005; 52:1585-1590.
20. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD: Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004; 239:788-797.
21. Yeh TS, Tseng JH, Chiu CT, Liu NJ, Chen TC, Jan YY, Chen MF: Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg. 2006; 244:248-253.
22. Garofalo MC, Regine WF, Tan MT: On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer. Ann Surg. 2006; 244:332-333.
23. Wada K, Kozarek RA, Traverso LW: Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg. 2005; 189:632-636.
24. TakahashiH, Nakamori S, Nakahira S, Tsujie M, Takahshi Y, Marubashi S, Miyamoto A, Takeda Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M: Surgical outcomes of non-invasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas. Ann Surg Oncol. 2006; 13:955-960.
25. D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC: Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg. 2004; 239:400-408.